BRCA1 and ovarian carcinoma: Analyzing the 20 BRCA1-methylation-positive ovarian cancer patients separately revealed similar results to the whole group of OC patients, where the expression of miR-155-5p was significantly higher in patients as compared to controls (p = 0.043) (Figure 4D).